Axcellerate Pharma deploys a unique combination of assets and operational capabilities to provide high quality CRO and CDMO services. Axcellerate Pharma is ideally positioned to accommodate drug product development activities as well as the manufacture of early cGMP clinical supplies of drug substance and sterile drug product for both large and small molecules. Axcellerate’s capabilities include a full complement of organic synthesis, analytical methods development and biological services. In addition, Axcellerate Pharma has dedicated process areas for biologics development, chemical development and sterile manufacturing of drug product including lyophilization.
Our Services
Axcellerate Pharma offers expertise in the manufacture of various types of Services. Please click here to learn more about our services.
Our Capabilities
Axcellerate Pharma have capabilities in many areas. Please click here to learn more about our capabilities.
Alliance Partners
March 20 – 23
DCAT, NY
Learn More
March 21 – 23
Interphex, New York
Learn More
May 16 – 18
CPhI North America, Philadelphia
Learn More
June 19 – 22
BIO, San Diego
Learn More
September 14-15
Contract Pharma, NJ
Learn More
Commercial Manufacturing | CRO/CDMO
Generics
Lyophilization
Control Substances
Hormones & Steroids
Cytotoxic, Oncology
Sterile Injectables
Vials
Syringes
Cartridges
Bags
Biologics
Mammalian Cell Culture
Microbial Fermentation
Oligonucleotides
PEGylation